The global polycystic ovarian syndrome treatment market was valued at US$ 2.7 billion in 2023. The market is anticipated to expand at a CAGR of 4.6% from 2024 to 2034 and is expected to reach US$ 4.3 billion by 2034. Rising diagnosis rates, increasing healthcare expenditure, and growing awareness regarding fertility and metabolic health are driving market growth globally. PCOS treatment...